Open access · OA
via OpenAlex
Body Management: Mesenchymal Stem Cells Control the Internal Regenerator
Arnold I. Caplan, ROBERT J. HARIRI
Stem Cells Translational Medicine · 2015 · ▲ 64 citations
Abstract
UNLABELLED: SummaryIt has been assumed that adult tissues cannot regenerate themselves. With the current understanding that every adult tissue has its own intrinsic progenitor or stem cell, it is now clear that almost all tissues have regenerative potential partially related to their innate turnover dynamics. Moreover, it appears that a separate class of local cells originating as perivascular cells appears to provide regulatory oversight for localized tissue regeneration. The management of this regeneration oversight has a profound influence on the use of specific cells for cell therapies as a health care delivery tool set. The multipotent mesenchymal stem cell (MSC), now renamed the medicinal signaling cell, predominantly arises from pericytes released from broken and inflamed blood vessels and appears to function as both an immunomodulatory and a regeneration mediator. MSCs are being tested for their management capabilities to produce therapeutic outcomes in more than 480 clinical trials for a wide range of clinical conditions. Local MSCs function by managing the body's primary repair and regeneration activities. Supplemental MSCs can be provided from either endogenous or exogenous sources of either allogeneic or autologous origin. This MSC-based therapy has the potential to change how health care is delivered. These medicinal cells are capable of sensing their surroundings. Also, by using its complex signaling circuitry, these cells organize site-specific regenerative responses as if these therapeutic cells were well-programmed modern computers. Given these facts, it appears that we are entering a new age of cellular medicine. SIGNIFICANCE: This report is a perspective from an active scientist and an active entrepreneur and commercial leader. It is neither a comprehensive review nor a narrowly focused treatise. The broad themes and the analogy to the working component of a computer and that of a cell are meant to draw several important scientific principles and health care themes together into the thesis that regenerative medicine is a constant throughout life and its management is the next frontier of health care. Mesenchymal stem cells are used as the central connection in the broad theme, not as multipotent progenitors but rather as an important control element in the natural local regeneration process.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5966/sctm.2014-0291
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Caplan, A.I., & HARIRI, R.J. (2015). Body Management: Mesenchymal Stem Cells Control the Internal Regenerator. <em>Stem Cells Translational Medicine</em>. https://doi.org/10.5966/sctm.2014-0291
Vancouver
Caplan AI, HARIRI RJ. Body Management: Mesenchymal Stem Cells Control the Internal Regenerator. Stem Cells Translational Medicine. 2015. doi:10.5966/sctm.2014-0291.
BibTeX
@article{arnold2015BodyMa,
title = {Body Management: Mesenchymal Stem Cells Control the Internal Regenerator},
author = {Arnold I. Caplan and ROBERT J. HARIRI},
journal = {Stem Cells Translational Medicine},
year = {2015},
doi = {10.5966/sctm.2014-0291},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
World Journal of Experimental Medicine 2024
Open access · CC-BY
Anti-aging based on stem cell therapy: A scoping review
The Journals of Gerontology Series A 2018
Citation only
Mesenchymal Stem Cells for Periodontal Tissue Regeneration in Elderly Patients
Stem Cells Translational Medicine 2017
Open access · CC-BY
Mesenchymal Stem Cells: Time to Change the Name!
Europe PMC (PubMed Central) 2012
Preprint · OA
Mesenchymal stem cells, aging and regenerative medicine.
Journal of Translational Medicine 2025
Open access · CC-BY
Unleashing endogenous regeneration by senolytics
Stem Cell Research & Therapy 2022
Open access · CC-BY